Assignee
MODERNA THERAPEUTICS INC
US·33 granted patents·42 pending applications·2,903 citations·filing 2012–2016
Top patents by PatentIndex Score
75 records- 0199US9675668B2Modified polynucleotides encoding hepatitis A virus cellular receptor 2MODERNA THERAPEUTICS INC·Filed 2013·Granted Jun 13, 2017·109 cites·14 claims
- 0299US9657295B2Modified nucleosides, nucleotides, and nucleic acids, and uses thereofMODERNA THERAPEUTICS INC·Filed 2016·Granted May 23, 2017·46 cites·20 claims
- 0399US9587003B2Modified polynucleotides for the production of oncology-related proteins and peptidesMODERNA THERAPEUTICS INC·Filed 2016·Granted Mar 7, 2017·67 cites·19 claims
- 0499US9572896B2In vivo production of proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Feb 21, 2017·75 cites·11 claims
- 0599US9572897B2Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteinsMODERNA THERAPEUTICS INC·Filed 2016·Granted Feb 21, 2017·65 cites·19 claims
- 0699US9504734B2Modified polynucleotides for the production of nuclear proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Nov 29, 2016·56 cites·19 claims
- 0799US9334328B2Modified nucleosides, nucleotides, and nucleic acids, and uses thereofMODERNA THERAPEUTICS INC·Filed 2013·Granted May 10, 2016·110 cites·10 claims
- 0899US9301993B2Modified polynucleotides encoding apoptosis inducing factor 1MODERNA THERAPEUTICS INC·Filed 2013·Granted Apr 5, 2016·89 cites·17 claims
- 0999US9303079B2Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteinsMODERNA THERAPEUTICS INC·Filed 2013·Granted Apr 5, 2016·190 cites·15 claims
- 1099US9283287B2Modified polynucleotides for the production of nuclear proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Mar 15, 2016·84 cites·24 claims
- 1199US9254311B2Modified polynucleotides for the production of proteinsMODERNA THERAPEUTICS INC·Filed 2013·Granted Feb 9, 2016·126 cites·14 claims
- 1299US9233141B2Modified polynucleotides for the production of proteins associated with blood and lymphatic disordersMODERNA THERAPEUTICS INC·Filed 2013·Granted Jan 12, 2016·104 cites·8 claims
- 1399US9220792B2Modified polynucleotides encoding aquaporin-5MODERNA THERAPEUTICS INC·Filed 2013·Granted Dec 29, 2015·101 cites·7 claims
- 1499US9220755B2Modified polynucleotides for the production of proteins associated with blood and lymphatic disordersMODERNA THERAPEUTICS INC·Filed 2013·Granted Dec 29, 2015·118 cites·18 claims
- 1599US9221891B2In vivo production of proteinsMODERNA THERAPEUTICS INC·Filed 2013·Granted Dec 29, 2015·113 cites·13 claims
- 1699US9192651B2Modified polynucleotides for the production of secreted proteinsMODERNA THERAPEUTICS INC·Filed 2013·Granted Nov 24, 2015·103 cites·9 claims
- 1799US9181319B2Engineered nucleic acids and methods of use thereofMODERNA THERAPEUTICS INC·Filed 2014·Granted Nov 10, 2015·94 cites·9 claims
- 1899US9114113B2Modified polynucleotides encoding citeD4MODERNA THERAPEUTICS INC·Filed 2013·Granted Aug 25, 2015·121 cites·15 claims
- 1999US9107886B2Modified polynucleotides encoding basic helix-loop-helix family member E41MODERNA THERAPEUTICS INC·Filed 2013·Granted Aug 18, 2015·122 cites·15 claims
- 2099US9095552B2Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1MODERNA THERAPEUTICS INC·Filed 2013·Granted Aug 4, 2015·121 cites·15 claims
- 2199US9089604B2Modified polynucleotides for treating galactosylceramidase protein deficiencyMODERNA THERAPEUTICS INC·Filed 2014·Granted Jul 28, 2015·121 cites·16 claims
- 2299US9061059B2Modified polynucleotides for treating protein deficiencyMODERNA THERAPEUTICS INC·Filed 2014·Granted Jun 23, 2015·208 cites·16 claims
- 2399US8980864B2Compositions and methods of altering cholesterol levelsMODERNA THERAPEUTICS INC·Filed 2013·Granted Mar 17, 2015·143 cites·5 claims
- 2498US9149506B2Modified polynucleotides encoding septin-4MODERNA THERAPEUTICS INC·Filed 2013·Granted Oct 6, 2015·39 cites·15 claims
- 2598US9050297B2Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocatorMODERNA THERAPEUTICS INC·Filed 2013·Granted Jun 9, 2015·32 cites·17 claims
- 2697US9464124B2Engineered nucleic acids and methods of use thereofMODERNA THERAPEUTICS INC·Filed 2014·Granted Oct 11, 2016·188 cites·17 claims
- 2797US9295689B2Formulation and delivery of PLGA microspheresMODERNA THERAPEUTICS INC·Filed 2013·Granted Mar 29, 2016·98 cites·9 claims
- 2897US9216205B2Modified polynucleotides encoding granulysinMODERNA THERAPEUTICS INC·Filed 2013·Granted Dec 22, 2015·15 cites·15 claims
- 2996US9782462B2Modified polynucleotides for the production of proteins associated with human diseaseMODERNA THERAPEUTICS INC·Filed 2016·Granted Oct 10, 2017·7 cites·19 claims
- 3096US9447164B2Engineered nucleic acids and methods of use thereofMODERNA THERAPEUTICS INC·Filed 2015·Granted Sep 20, 2016·15 cites·13 claims
- 3195US9827332B2Modified polynucleotides for the production of proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Nov 28, 2017·7 cites·33 claims
- 3292US9271996B2Formulation and delivery of PLGA microspheresMODERNA THERAPEUTICS INC·Filed 2013·Granted Mar 1, 2016·12 cites·9 claims
- 3392US9255129B2Modified polynucleotides encoding SIAH E3 ubiquitin protein ligase 1MODERNA THERAPEUTICS INC·Filed 2013·Granted Feb 9, 2016·4 cites·16 claims
- 3470US2015051268A1Methods of increasing the viability or longevity of an organ or organ explantMODERNA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3567US2015307542A1Modified nucleic acid molecules and uses thereofMODERNA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3666US2016354493A1Modified nucleic acid molecules and uses thereofMODERNA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3766US2016354491A1Modified nucleic acid molecules and uses thereofMODERNA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3866US2016348099A1Modified nucleic acid molecules and uses thereofMODERNA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3965US2016354492A1Modified nucleic acid molecules and uses thereofMODERNA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4065US2016354490A1Modified nucleic acid molecules and uses thereofMODERNA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4165US2016243221A1Compositions and methods for tolerizing cellular systemsMODERNA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4263US2016193299A1Modified nucleoside, nucleotide, and nucleic acid compositionsMODERNA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4362US2015005372A1Compositions and methods of altering cholesterol levelsMODERNA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4461US2016136236A1Compositions and Methods of Altering Cholesterol LevelsMODERNA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4561US2014206852A1Signal-sensor polynucleotidesMODERNA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4659US2014343129A1Modified nucleic acids, and acute care uses thereofMODERNA THERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 4758US2016022840A1Heterologous untranslated regions for mrnaMODERNA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4858US2016271272A1Engineered nucleic acids and methods of use thereofMODERNA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4957US2016024181A1Long-lived polynucleotide moleculesMODERNA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 5056US2017056528A1Modified nucleosides, nucleotides, and nucleic acids, and uses thereofMODERNA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Showing the top 50 of 75 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when MODERNA THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →